Necessity of early intervention for IgG4-related disease-delayed treatment induces fibrosis progression

Rheumatology (United Kingdom)

Volumn 52, Issue 4, 2013, Pages 679-683

  Shimizu, Yui ^a   Yamamoto, Motohisa ^a   Naishiro, Yasuyoshi ^a   Sudoh, Gohta ^a   Ishigami, Keisuke ^a   Yajima, Hidetaka ^a   Tabeya, Tetsuya ^a   Matsui, Mikiko ^a   Suzuki, Chisako ^a   Takahashi, Hiroki ^a   Seki, Nobuhiko ^a   Himi, Tetsuo ^a   Yamashita, Ken ^a   Noguchi, Hiroko ^a   Hasegawa, Tadashi ^a   Suzuki, Yasuo ^b   Honda, Saho ^c   Abe, Takashi ^d   Imai, Kohzoh ^e   Shinomura, Yasuhisa ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TEINE KEIJINKAI HOSPITAL   (Japan)

^c Sapporo General Hospital of Hokkaido Railway Company   (Japan)

^d Kushiro City General Hospital   (Japan)

^e UNIVERSITY OF TOKYO   (Japan)

Author keywords

Autoimmune pancreatitis; Early intervention; Fibrosis; IgG4; Mikulicz's disease

Indexed keywords

GLUCOCORTICOID;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; DRUG EFFICACY; EARLY INTERVENTION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN G4 RELATED DISEASE; IMMUNOPATHOLOGY; LYMPH FOLLICLE; MALE; MIKULICZ DISEASE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SALIVATION; SUBMANDIBULAR GLAND; THERAPY DELAY;

AGED; DISEASE PROGRESSION; EARLY MEDICAL INTERVENTION; FEMALE; FIBROSIS; GLUCOCORTICOIDS; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; MIKULICZ' DISEASE; PREDNISOLONE; RETROSPECTIVE STUDIES; SALIVA; SUBMANDIBULAR GLAND; TIME FACTORS; TREATMENT OUTCOME;

EID: 84875615264     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kes358     Document Type: Article

References (15)

1. Yamamoto M, Harada S, Ohara M et al. Clinical and pathological differences between Mikulicz's disease and Sjö gren's syndrome. Rheumatology 2005;44:227-34.
2. Yamamoto M, Ohara M, Suzuki C et al. Elevated IgG4 concentrations in serum of patients with Mikulicz's disease. Scand J Rheumatol 2004;33:432-3.
3. Hamano H, Kawa S, Horiuchi A et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 2001;344:732-8.
4. Hamano H, Kawa S, Ochi Y et al. Hydronephrosis associated with retroperitoneal fibrosis and sclerosing pancreatitis. Lancet 2002;359:1403-4.
5. Saeki T, Saito A, Yamazaki H et al. Tubulointerstitial nephritis associated with IgG4-related systemic disease. Clin Exp Nephrol 2007;11:168-73.
6. Ryu JH, Sekiguchi H, Yi ES. Pulmonary manifestations of immunoglobulin G4-related sclerosing disease. Eur Respir J 2012;39:180-6.
7. Yamamoto M, Takahashi H, Shinomura Y. Mikulicz's disease and the extraglandular lesions. Curr Immunol Rev 2011;7:162-71.
8. Kohler PF, Winter ME. A quantitative test for xerostomia: the Saxon test, an oral equivalent of the Schirmer test. Arthritis Rheum 1985;28:1128-32.
9. Ozden I, Dizdaroǧ lu F, Poyanli A, Emre A. Spontaneous regression of a pancreatic head mass and biliary obstruction due to autoimmune pancreatitis. Pancreatology 2005;5:300-3.
10. Miura H, Miyachi Y. IgG4-related retroperitoneal fibrosis and sclerosing cholangitis independent of autoimmune pancreatitis. A recurrent case after a 5-year history of spontaneous remission. JOP 2009;6: 432-7.
11. Kubota K, Watanabe S, Uchiyama T et al. Factors predictive of relapse and spontaneous remission of autoimmune pancreatitis patients treated/not treated with corticosteroids. J Gastroenterol 2011;46: 834-42.
12. Kamisawa T, Okazaki K, Kawa S et al. Japanese consensus guidelines for management of autoimmune pancreatitis: III. Treatment and prognosis of AIP. J Gastroenterol 2010;45:471-7.
13. Yamamoto M, Harada S, Ohara M et al. Beneficial effects of steroid therapy for Mikulicz's disease. Rheumatology 2005;44:1322-3.
14. Tsubota K, Fujita H, Tsuzaka K, Takeuchi T. Mikulicz's disease and Sjö gren's syndrome. Invest Ophthalmol Vis Sci 2000;41:1666-73.
15. Mnganelli P, Fietta P. Apoptosis and Sjögren's syndrome. Semin Arthritis Rheum 2003;33:49-65.